Avandia :: Safety alert on Avandia – a timely action of FDA

The U.S. Food and Drug Administration (FDA) issued a safety alert on Avandia, diabetes drug approved to treat type 2 diabetes. I believe safety alert on Glaxo’s diabetes drug Avandia is a timely action by US FDA health agency, remarked Dr. Anil Singhal.

Diabetes :: Diabetics in nursing homes need improved care

Ohio University College of Osteopathic Medicine researchers find that elderly diabetics in extended-care facilities need improved treatment protocols for diabetes. Current standards of care fail to meet American Diabetes Association standards for outpatient diabetics.

Multiple Sclerosis :: Withdrawn MS drug returns to market

Just months after receiving FDA approval, natalizumab, a medication for the treatment of multiple sclerosis (MS) and other inflammatory disorders, was voluntarily withdrawn by its manufacturers after three patients developed a brain infection known as Progressive Multifocal Leukoencephalopathy (PML).

Breast Cancer :: Possible new breast cancer gene

Researchers at the Abramson Family Cancer Research Institute of the University of Pennsylvania and the Dana-Farber Cancer Institute describe in this week?s issue of Science a new candidate breast-cancer susceptibility gene. The Rap80 gene is required for the normal DNA-repair function of the well-known breast cancer gene BRCA1.

Dr. Anil Singhal Homeopathic Doctor | Dr. Anil Singhal's Blog | Manan - My Memoir by Dr. Anil Singhal | Boger's Legacy | Organon of Medicine | Health Newstrack